ID   U-CH17PII
AC   CVCL_B6R8
DR   Wikidata; Q112041873
WW   Info; Chordoma Foundation; -; https://www.chordomafoundation.org/researchers/disease-models/u-ch17pii/
CC   Doubling time: 3-4 days (Chordoma Foundation).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Heterozygous or homozygous (from autologous cell lines U-CH17M; U-CH17P; U-CH17S).
CC   Derived from site: In situ; Bone, sacrum; UBERON=UBERON_0003690.
ST   Source(s): Chordoma Foundation
ST   Amelogenin: X,Y
ST   CSF1PO: 12,14
ST   D13S317: 11
ST   D16S539: 13
ST   D18S51: 12
ST   D3S1358: 18
ST   D7S820: 9,12
ST   D8S1179: 9,12
ST   Penta D: 12
ST   Penta E: 11,14
ST   TH01: 9.3
ST   TPOX: 11
DI   NCIt; C129927; Sacral chordoma
DI   ORDO; Orphanet_178; Chordoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VR43 ! U-CH17M
OI   CVCL_VR44 ! U-CH17P
OI   CVCL_VR45 ! U-CH17S
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 8
//